TCR Reporter Assay

JC Jennifer Currenti
BL Becker M.P. Law
KQ Kai Qin
MJ Mina John
MP Mark A. Pilkinton
AB Anju Bansal
SL Shay Leary
RR Ramesh Ram
AC Abha Chopra
RG Rama Gangula
LY Ling Yue
CW Christian Warren
LB Louise Barnett
EA Eric Alves
WM Wyatt J. McDonnell
AS Anuradha Sooda
SH Sonya L. Heath
SM Simon Mallal
PG Paul Goepfert
SK Spyros A. Kalams
SG Silvana Gaudieri
request Request a Protocol
ask Ask a question
Favorite

Specific TCR combinations were tested for their resultant induction of NFAT-driven luciferase output using a previously described protocol (23). For peptide presentation, single antigen lines for the relevant HLA allele were cultured and passaged at least once at 0.3×106cells/mL before peptide pulse in RPMI supplemented with 10% FBS, 1% L-glutamine and 1% penicillin streptomycin. Cells were washed with RPMI (no phenol red) supplemented with 10% FBS and 1% L-glutamine and resuspended at 1×106 cells/mL, with 50,000 cells added to each well of a U-bottom 96 well plate. Peptides at a final concentration of 30ng/µL (with serial 10-fold dilutions) were added and incubated overnight at 37°C and 5% CO2 in a final volume of 70µL. After 24 hours, transfected Jurkat E6.1 cells were counted and resuspended at 1×106 cells/mL, with 50,000 cells being added to target cells in a final volume of 100µL. Cells were co-cultured for six hours and transferred to a white Cliniplate (ThermoScientific) prior to the addition of 100µL Bright-Glo (Promega) with an incubation of 10 minutes in the dark at room temperature. Luciferase output was measured on a DTX 880 multimode detector (Beckman Coulter) using 3000ms integration. PMA/Ionomycin was used as a positive control with four negative controls: 1) media only; 2) Jurkat only; 3) Jurkat and APCs; and 4) Jurkat and peptide. All conditions were in duplicate.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A